PAVmed Inc
F:1P5
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PAVmed Inc
F:1P5
|
US |
|
W
|
Walgreens Boots Alliance Inc
XMUN:W8A
|
US |
|
C
|
Curtiss-Wright Corp
F:CWT
|
US |
|
C
|
CenterPoint Energy Inc
DUS:HOU
|
US |
|
G
|
Getlink SE
OTC:GRPTF
|
FR |
|
Arqit Quantum Inc
NASDAQ:ARQQ
|
UK |
|
Seatrium Limited
F:S8N0
|
SG |
|
C
|
Credit Suisse Group AG
F:CSX
|
CH |
|
Essent Group Ltd
LSE:0U95
|
BM |
|
J
|
JMT Network Services PCL
SET:JMT
|
TH |
|
M
|
Medallion Financial Corp
SWB:MD5
|
US |
|
Primerica Inc
NYSE:PRI
|
US |
|
A
|
AXA SA
PAR:CSNV
|
FR |
|
K'S Holdings Corp
F:KSD
|
JP |
|
L
|
Lemonsoft Oyj
OMXH:LEMON
|
FI |
|
Haitong Securities Co Ltd
OTC:HAITY
|
CN |
|
R
|
Rheinmetall AG
XBER:RHM
|
DE |
|
S
|
Sula Vineyards Ltd
NSE:SULA
|
IN |
|
Regency Centers Corp
NASDAQ:REG
|
US |
|
D
|
DENTSPLY SIRONA Inc
XMUN:DY2
|
US |
|
S
|
Sasol Ltd
DUS:SAO
|
ZA |
|
Innovative Solutions and Support Inc
NASDAQ:ISSC
|
US |
Wall St Price Targets
1P5 Price Targets Summary
PAVmed Inc
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1P5's stock price target?
Not Available
1P5 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for PAVmed Inc?
Projected CAGR
206%
The compound annual growth rate for Revenue over the next 2 years is 206%.